207 related articles for article (PubMed ID: 31348230)
21. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
[TBL] [Abstract][Full Text] [Related]
22. Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer.
Zhao H; Huang T; Li H
Surgery; 2019 Jul; 166(1):55-60. PubMed ID: 30876667
[TBL] [Abstract][Full Text] [Related]
23. Comparing the Prognostic Value of the Eighth Edition of the American Joint Committee on Cancer/Tumor Node Metastasis Staging System Between Papillary and Follicular Thyroid Cancer.
van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
Thyroid; 2018 Aug; 28(8):976-981. PubMed ID: 29848239
[TBL] [Abstract][Full Text] [Related]
24. The prognostic value of E-cadherin in gastric cancer: a meta-analysis.
Xing X; Tang YB; Yuan G; Wang Y; Wang J; Yang Y; Chen M
Int J Cancer; 2013 Jun; 132(11):2589-96. PubMed ID: 23169395
[TBL] [Abstract][Full Text] [Related]
25. [Expression and significance of serum E-cadherin in patients with papillary thyroid carcinoma].
Sun L; Wang DM; Zhang WJ; Zhang J; Wu JF
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan; 31(2):123-126. PubMed ID: 29871201
[No Abstract] [Full Text] [Related]
26. Reduced expression of E-cadherin correlates with poor prognosis and unfavorable clinicopathological features in gastric carcinoma: a meta-analysis.
Lu G; Cai Z; Jiang R; Tong F; Tu J; Chen Y; Fu Y; Sun J; Zhang T
Aging (Albany NY); 2024 Jun; 16():. PubMed ID: 38870263
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological predictors of occult lateral neck lymph node metastasis in papillary thyroid cancer: A meta-analysis.
Zhan S; Luo D; Ge W; Zhang B; Wang T
Head Neck; 2019 Jul; 41(7):2441-2449. PubMed ID: 30938923
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological significance of loss of p27kip1 expression in papillary thyroid carcinoma.
Kim NY; Kim JH; Pyo JS; Jin Cho W
Int J Biol Markers; 2017 May; 32(2):e255-e259. PubMed ID: 27834461
[TBL] [Abstract][Full Text] [Related]
29. Associations between BRAF(V600E) and prognostic factors and poor outcomes in papillary thyroid carcinoma: a meta-analysis.
Liu C; Chen T; Liu Z
World J Surg Oncol; 2016 Sep; 14(1):241. PubMed ID: 27600854
[TBL] [Abstract][Full Text] [Related]
30. A comparison of the clinicopathological features and prognoses of the classical and the tall cell variant of papillary thyroid cancer: a meta-analysis.
Liu Z; Zeng W; Chen T; Guo Y; Zhang C; Liu C; Huang T
Oncotarget; 2017 Jan; 8(4):6222-6232. PubMed ID: 28009980
[TBL] [Abstract][Full Text] [Related]
31. E-cadherin: a differentiation marker in thyroid malignancies.
Brabant G; Hoang-Vu C; Cetin Y; Dralle H; Scheumann G; Mölne J; Hansson G; Jansson S; Ericson LE; Nilsson M
Cancer Res; 1993 Oct; 53(20):4987-93. PubMed ID: 8402689
[TBL] [Abstract][Full Text] [Related]
32. Loss of cellular polarity/cohesiveness in the invasive front of papillary thyroid carcinoma, a novel predictor for lymph node metastasis; possible morphological indicator of epithelial mesenchymal transition.
Liu Z; Kakudo K; Bai Y; Li Y; Ozaki T; Miyauchi A; Taniguchi E; Mori I
J Clin Pathol; 2011 Apr; 64(4):325-9. PubMed ID: 21296795
[TBL] [Abstract][Full Text] [Related]
33. [The expression and clinical significance of EphA2 and E-cadherin in papillary thyroid carcinoma].
Liu Y; Miao Y; Li X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Jun; 29(11):1020-3. PubMed ID: 26536708
[TBL] [Abstract][Full Text] [Related]
34. [Prognostic value of e-cadherin in papillary thyroid carcinoma].
Walgenbach S; Sternheim E; Bittinger F; Görges R; Andreas J; Junginger T
Chirurg; 1998 Feb; 69(2):186-90. PubMed ID: 9551263
[TBL] [Abstract][Full Text] [Related]
35. Predictors of metastasis to lymph nodes posterior to the right recurrent laryngeal nerve in differentiated thyroid carcinoma: A prospective study.
Liu Z; Sun M; Xiao Y; Yang J; Zhang T; Zhao Y
Asian J Surg; 2017 Jul; 40(4):270-277. PubMed ID: 26948300
[TBL] [Abstract][Full Text] [Related]
36. Prognostic variables of papillary and follicular thyroid carcinoma patients with lymph node metastases and without distant metastases.
Lin JD; Liou MJ; Chao TC; Weng HF; Ho YS
Endocr Relat Cancer; 1999 Mar; 6(1):109-15. PubMed ID: 10732793
[TBL] [Abstract][Full Text] [Related]
37. Recurrence factors and prevention of complications of pediatric differentiated thyroid cancer.
Wang C; Chen X; Wei X; Chen F; Wang Y; Shen Z
Asian J Surg; 2017 Jan; 40(1):55-60. PubMed ID: 27697309
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for cervical lymph node metastasis in papillary thyroid microcarcinoma: A meta-analysis.
Vorasubin N; Nguyen C; Wang M
Ear Nose Throat J; 2016 Feb; 95(2):73-7. PubMed ID: 26930333
[TBL] [Abstract][Full Text] [Related]
39. Aerodigestive tract invasion by well-differentiated thyroid carcinoma: diagnosis, management, prognosis, and biology.
McCaffrey JC
Laryngoscope; 2006 Jan; 116(1):1-11. PubMed ID: 16481800
[TBL] [Abstract][Full Text] [Related]
40. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study.
Lundgren CI; Hall P; Dickman PW; Zedenius J
Cancer; 2006 Feb; 106(3):524-31. PubMed ID: 16369995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]